NCT07745478

Brief Summary

To evaluate the effectiveness of the E-MOTE Emotional Care Program, delivered through the Kebbi robot and the LINE Official Account, for patients newly diagnosed with gynecologic cancer undergoing surgery. The primary outcomes are psychological distress , and the secondary outcomes are physical symptoms, stress index, and quality of life.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
23mo left

Started Sep 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 30, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 4, 2026

Completed
28 days until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2028

Last Updated

August 4, 2026

Status Verified

July 1, 2026

Enrollment Period

1.9 years

First QC Date

July 30, 2026

Last Update Submit

July 30, 2026

Conditions

Keywords

Artifical inteligenceRobotEmotional assessmentPsychological support

Outcome Measures

Primary Outcomes (2)

  • Distress

    Investigators utilized the Distress Thermometer(DT) as the primary outcome measure. The scale uses a 11 Liker scale, where 0 indicates no distress at all and 10 represents the most severe distress.Higher score indicates a more severe distress. When the score is 4 or higher, a Problem List (PL) is used to further identify factors contributing to the emotional distress.

    Measurements will be taken before the intervention, three days after surgery, and one week after discharge.

  • Depression

    Investigators utilized the Patient Health Questionnaire (PHQ-9) as the primary outcome measure to assess depression. The scale consists of 9 items, each rated on a 4-point Likert scale (0 = not at all, 3 = nearly every day). The total score ranges from 0 to 27, and depression severity can be categorized as mild (5-9), moderate (10-14), moderately severe (15-19), and severe (20 or above).Higher score indicates a more severe depression.

    Measurements will be taken before the intervention, three days after surgery, and one week after discharge

Secondary Outcomes (3)

  • Quality of Life Measurement

    Measurements will be taken before the intervention, three days after surgery, and one week after discharge

  • Symptom Severity

    Measurements will be taken before the intervention, three days after surgery, and one week after discharge

  • Stress Index

    Measurements will be taken before the intervention, three days after surgery, and one week after discharge

Study Arms (2)

Control Group

NO INTERVENTION

Routine care

Intervention Group

EXPERIMENTAL

The intervention group will receive the E-MOTE program, which includes emotional assessments, a self-relaxation training session, and a Q\&A session delivered via the Kebbi AI robot during hospitalization. After discharge, participants will continue to receive the program through the LINE Official Account.

Other: E-MOTE group

Interventions

Participants in the experimental group will receive the E-MOTE program during hospitalization on the day before surgery, postoperative day 1, and postoperative day 2 via the AI robot. The intervention includes an emotional assessment, followed by dialogue modules tailored to the participant's level of emotional distress, emotion-generated empathetic conversations, a self-affirmation relaxation training session, and a Q\&A session. After discharge, participants will continue to receive the E-MOTE program through the LINE Official Account.

Intervention Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older.
  • Diagnosed with gynecologic cancer and undergoing surgery.
  • Willing to receive E-MOTE robot and wear a smart wearable device.
  • Willing to complete pre-test and post-test questionnaires.

You may not qualify if:

  • Unable to communicate clearly.
  • Unwilling or unable to participate in the study in its entirety.
  • \*\*\*Nurse\*\*\*
  • Aged 18 years or older.
  • As a clinical nurse and has cared for patients who received the E-MOTE robot
  • \- Unwilling to participate in the qualitative interview.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University

Taipei, Taiwan

Location

Central Study Contacts

Yun-Hsiang Lee Associate Professor, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This intervention module will first classify different levels of emotional distress using the PHQ-8, then provide corresponding and tailored dialogue modules . These will be accompanied by emotion-generated empathetic conversations for deeper engagement, followed by a guided session of self-affirmation relaxation training. Subsequently, a Q\&A session on the self-affirmation relaxation training will be conducted to reinforce the practice.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 30, 2026

First Posted

August 4, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

July 31, 2028

Study Completion (Estimated)

July 31, 2028

Last Updated

August 4, 2026

Record last verified: 2026-07

Locations